PULMONARY CANCER

Clinical trials for PULMONARY CANCER explained in plain language.

Never miss a new study

Get alerted when new PULMONARY CANCER trials appear

Sign up with your email to follow new studies for PULMONARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet finished but already full! 1 Terminated 1

New drug combo targets tough cancers with KRAS mutation

Disease control Ongoing

This study tests a new drug called JDQ443, alone or with other medicines, in people with advanced solid tumors that have a specific KRAS G12C mutation. The goal is to see if the drug is safe and can shrink tumors. About 344 adults whose cancer has not responded to standard treatm…

Matched conditions: PULMONARY CANCER

Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated May 05, 2026 11:56 UTC

PULMONARY CANCER

Get alerted when new PULMONARY CANCER trials appear

New drug combo targets tough cancers with KRAS mutation